<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">86022</article-id><article-id pub-id-type="doi">10.7554/eLife.86022</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Ketamine's rapid antidepressant effects are mediated by Ca<sup>2+</sup>-permeable AMPA receptors</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-303345"><name><surname>Zaytseva</surname><given-names>Anastasiya</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-303346"><name><surname>Bouckova</surname><given-names>Evelina</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-303347"><name><surname>Wiles</surname><given-names>McKennon J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-303348"><name><surname>Wustrau</surname><given-names>Madison H</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-303349"><name><surname>Schmidt</surname><given-names>Isabella G</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-303350"><name><surname>Mendez-Vazquez</surname><given-names>Hadassah</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-303351"><name><surname>Khatri</surname><given-names>Latika</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-137132"><name><surname>Kim</surname><given-names>Seonil</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0451-2180</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Molecular, Cellular and Integrative Neurosciences Program</institution>, <institution>Colorado State University</institution>, <addr-line><named-content content-type="city">Fort Collins</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Biomedical Sciences</institution>, <institution>Colorado State University</institution>, <addr-line><named-content content-type="city">Fort Collins</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Cell Biology</institution>, <institution>New York University</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-46365"><name><surname>Scharfman</surname><given-names>Helen E</given-names></name><role>Reviewing editor</role><aff><institution>Nathan Kline Institute and New York University Langone Medical Center</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>seonil.kim@colostate.edu</email> (SK);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>26</day><month>06</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e86022</elocation-id><history><date date-type="received"><day>07</day><month>01</month><year>2023</year></date><date date-type="accepted"><day>23</day><month>06</month><year>2023</year></date></history><permissions><copyright-statement>Â© 2023, Zaytseva et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Zaytseva et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-86022-v1.pdf"/><abstract><p>Ketamine is shown to enhance excitatory synaptic drive in multiple brain areas, which is presumed to underlie its rapid antidepressant effects. Moreover, ketamine's therapeutic actions are likely mediated by enhancing neuronal Ca<sup>2+</sup> signaling. However, ketamine is a noncompetitive NMDA receptor (NMDAR) antagonist that reduces excitatory synaptic transmission and postsynaptic Ca<sup>2+</sup> signaling. Thus, it is a puzzling question how ketamine enhances glutamatergic and Ca<sup>2+</sup> activity in neurons to induce rapid antidepressant effects while blocking NMDARs in the hippocampus. Here, we find that ketamine treatment in cultured mouse hippocampal neurons significantly reduces Ca<sup>2+</sup> and calcineurin activity to elevate AMPA receptor (AMPAR) subunit GluA1 phosphorylation. This phosphorylation ultimately leads to the expression of Ca<sup>2+</sup>-Permeable, GluA2-lacking, and GluA1-containing AMPARs (CP-AMPARs). The ketamine-induced expression of CP-AMPARs enhances glutamatergic activity and glutamate receptor plasticity in cultured hippocampal neurons. Moreover, when a sub-anesthetic dose of ketamine is given to mice, it increases synaptic GluA1 levels, but not GluA2, and GluA1 phosphorylation in the hippocampus within one hour after treatment. These changes are likely mediated by ketamine-induced reduction of calcineurin activity in the hippocampus. Using the open field and tail suspension tests, we demonstrate that a low dose of ketamine rapidly reduces anxiety-like and depression-like behaviors in both male and female mice. However, when <italic>in vivo</italic> treatment of a CP-AMPAR antagonist abolishes the ketamine's effects on animals' behaviors. We thus discover that ketamine at the low dose promotes the expression of CP-AMPARs via reduction of calcineurin activity, which in turn enhances synaptic strength to induce rapid antidepressant actions.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007235</institution-id><institution>Colorado State University</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Zaytseva</surname><given-names>Anastasiya</given-names></name><name><surname>Bouckova</surname><given-names>Evelina</given-names></name><name><surname>Wiles</surname><given-names>McKennon J</given-names></name><name><surname>Wustrau</surname><given-names>Madison H</given-names></name><name><surname>Schmidt</surname><given-names>Isabella G</given-names></name><name><surname>Kim</surname><given-names>Seonil</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100005508</institution-id><institution>Boettcher Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Kim</surname><given-names>Seonil</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>NIH/NCATS Colorado CTSA Grant</institution></institution-wrap></funding-source><award-id>UL1 TR002535</award-id><principal-award-recipient><name><surname>Kim</surname><given-names>Seonil</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>NIA</institution></institution-wrap></funding-source><award-id>R03AG072102</award-id><principal-award-recipient><name><surname>Kim</surname><given-names>Seonil</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100006312</institution-id><institution>BrightFocus Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Kim</surname><given-names>Seonil</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#3408) of Colorado State University. The protocol was approved by the Committee on the Ethics of Animal Experiments of Colorado State University. All surgery was performed under urethane anesthesia, and every effort was made to minimize suffering.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Source Data files have been provided for Figures (Fig. 1-6) that contain the numerical data used to generate the figures.</p></sec><supplementary-material><ext-link xlink:href="elife-86022-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>